Environmental, Social and Governance (ESG)

Our purpose and values are fundamentally intertwined with promoting diversity, equity, and inclusion and doing our part to create a more just and sustainable world. This puts us in a position to impact society positively and we take that responsibility seriously. We have made great strides in addressing societal issues and made commitments to our employees, customers, patients, partners, vendors and investors to drive further progress. Please click below to learn more about our 2023 Environmental, Social and Governance progress.

ESG Report 2023 thumbnail cover
Women working at her desk

Diversity and inclusion

We believe that a more diverse workforce makes us stronger as we empower our customers to unlock better evidence from their clinical trials. That’s why we create opportunities at all levels for people of all genders, races, ethnicities, sexual orientations, and functional needs. Our Diversity Council and Employee Resource Groups (ERGs) help us create an inclusive culture for all.

Sustainability

Clario is committed to sustainable and ethical business practices. Our Strategic Sustainability Action Plan guides us as we embrace environmental accountability, invest in programs to reuse devices, reduce packaging, and implement tangible ways to improve the sustainability of our supply chain.

Man in a wheelchair having a video call at his desk

Labor and human rights

Our diversity and inclusion initiatives ensure that every person is valued and accepted for who they are. But we’re not stopping there. We’re working hard every day to create an environment where every person can thrive, be fairly compensated for their contributions, and realize opportunities for meaningful growth.

Improving inclusiveness in clinical trials

The lack of diversity in clinical trials leads to less reliable safety and efficacy data for specific patient populations. We are working to make clinical trials more innovative and inclusive through strategic partnerships with leading organizations and through our decentralized trial solutions that make it easier for a more diverse set of patients to participate.